The Changing Paradigm of Treating MASLD/MASH: At the Crossroads of Hepato-Cardiometabolic Care
The Changing Paradigm of Treating MASLD/MASH: At the Crossroads of Hepato-Cardiometabolic Care
December 05, 2024
12:00 PM - 01:30 PM EST
PBC Target Practice: Normalization Is the New Norm
PBC Target Practice: Normalization Is the New Norm
Initiating Second-Line Therapy: What, When, and Then What?
Initiating Second-Line Therapy: What, When, and Then What?
Don't Forget, There's a Sleepy Patient Behind Those Numbers
Don't Forget, There's a Sleepy Patient Behind Those Numbers
Don't Forget, There's an Itchy Patient Behind Those Numbers
Don't Forget, There's an Itchy Patient Behind Those Numbers
Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference
Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference
The Clinical Use of HER2-Targeted Therapies in Gastric Cancer: The Current and Emerging Landscape
The Clinical Use of HER2-Targeted Therapies in Gastric Cancer: The Current and Emerging Landscape
Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease
Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease
Practice Changing Highlights in G/GEJ Cancers: The Latest Data from Chicago
Practice Changing Highlights in G/GEJ Cancers: The Latest Data from Chicago
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
